nalmefene

(redirected from Revex)
Also found in: Dictionary, Acronyms.
Related to Revex: Revenue expenditure

nalmefene

 [nal´mĕ-fēn″]
an opioid antagonist, used as the hydrochloride salt in the treatment of opioid overdose and postoperative opioid depression.

nalmefene

/nal·me·fene/ (nal´mĕ-fēn″) an opioid antagonist, used as the hydrochloride salt in the treatment of opioid overdose and postoperative opioid depression.

nalmefene

(năl′mə-fēn′)
n.
A drug, C21H25NO3, used as an antagonist to narcotic drugs.

nalmefene

[nal′mĕfēn′]
an opioid antagonist, used as the hydrochloride salt in the treatment of opioid overdose and postoperative opioid depression.

nalmefene, nalmetrene

a narcotic antagonist, similar to naloxone, used to temporarily control obsessive behavior such as crib-biting in horses and self-mutilation in dogs.
Mentioned in ?
References in periodicals archive ?
The deal also offers the option to Rubik of acquiring Revex after three years.
The distribution deal will enable Rubik to resell Revex to its institutional, financial planning and industry superannuation fund clients and starting to make the combined COIN/Revex planning software available to non-aligned financial planners from February 2014.
Rubik managing director, wealth Wayne Wilson said the packages complemented each other, as the COIN-integrated Revex solution will aim for Rubik clients using its COIN software while the Easy Dealer software will cater to clients using non-COIN financial planning software like Xplan or Midwinter.